<DOC>
	<DOCNO>NCT01507935</DOCNO>
	<brief_summary>This study initiate investigate effect infant formula add specific prebiotic oligosaccharide reduction specific potential pathogen and/or toxin .</brief_summary>
	<brief_title>Colonisation Resistance Study</brief_title>
	<detailed_description />
	<criteria>Healthy term infant ( gestational age 37 42 week ) age 22.5 month inclusion Fully formula feed least one week ( applicable breastfeed reference group since infant must exclusively breastfed throughout study ) Parents ' guardian 's write informed consent Being wean inclusion ( introduction food formula breast milk . ) Moderate severe acute malnutrition , define weightforage sex 2 zscores median WHO growth standard Disorders require special diet ( food intolerance food allergy complaint reflux , constipation cramp ) Significant congenital abnormality could affect study result Use systemic antibiotic antimycotic drug 4 week precede study Investigator 's uncertainty willingness ability parent comply protocol requirement Participation study involve investigational market product concomitantly within two week prior entry study Gastroenteritis last two week inclusion</criteria>
	<gender>All</gender>
	<minimum_age>8 Weeks</minimum_age>
	<maximum_age>10 Weeks</maximum_age>
	<verification_date>September 2012</verification_date>
	<keyword>Healthy infant</keyword>
	<keyword>Infant formula</keyword>
	<keyword>Prebiotics oligosaccharide</keyword>
	<keyword>Colonisation Resistance</keyword>
	<keyword>Gut Microbiota</keyword>
</DOC>